نتائج البحث - "GA Tsaur"

المؤلفون: Druy AE; Laboratory of Molecular Oncology, Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.; Laboratory of the Cellular Therapy of Oncohematological Disorders, Research Institute of Medical Cell Technologies, Yekaterinburg, Russian Federation., Tsaur GA; Laboratory of the Cellular Therapy of Oncohematological Disorders, Research Institute of Medical Cell Technologies, Yekaterinburg, Russian Federation.; Pediatric Oncology and Hematology Center, Regional Children's Hospital, Yekaterinburg, Russian Federation.; Chair of Laboratory Medicine, Ural State Medical University, Yekaterinburg, Russian Federation., Shorikov EV; PET-Technology Center of Nuclear Medicine, Yekaterinburg, Russian Federation., Tytgat GAM; Princess Máxima Centre for Pediatric Oncology (PMC), Utrecht, The Netherlands., Fechina LG; Laboratory of the Cellular Therapy of Oncohematological Disorders, Research Institute of Medical Cell Technologies, Yekaterinburg, Russian Federation.; Pediatric Oncology and Hematology Center, Regional Children's Hospital, Yekaterinburg, Russian Federation.

المصدر: Cancer biomarkers : section A of Disease markers [Cancer Biomark] 2022; Vol. 34 (4), pp. 661-671.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: IOS Press Country of Publication: Netherlands NLM ID: 101256509 Publication Model: Print Cited Medium: Internet ISSN: 1875-8592 (Electronic) Linking ISSN: 15740153 NLM ISO Abbreviation: Cancer Biomark Subsets: MEDLINE

مواضيع طبية MeSH: MicroRNAs*/genetics , Neuroblastoma*/genetics , Neuroblastoma*/therapy , Telomerase*/genetics, Gene Expression Regulation, Neoplastic ; Humans ; Prognosis ; Proportional Hazards Models

8

دورية أكاديمية

Exome, transcriptome and miRNA analysis don't reveal any molecular markers of TKI efficacy in primary CML patients.

المؤلفون: Lavrov AV; Laboratory of Mutagenesis, Federal State Budgetary Institution, Research Centre for Medical Genetics, Moskvorechie str., 1, Moscow, Russian Federation, 115522. alexandervlavrov@gmail.com.; Department of Molecular and Cellular Genetics, State Budgetary Educational Institution of Higher Professional Education 'Russian National Research Medical University named after N.I. Pirogov' of Ministry of Health of the Russian Federation, Ostrovityanova str., 1, Moscow, Russian Federation, 117997. alexandervlavrov@gmail.com., Chelysheva EY; Scientific and Advisory Department of Chemotherapy of Myeloproliferative disorders, Federal State-Funded Institution National Research Center for Hematology of the Ministry of Healthcare of the Russian Federation, Novy Zykovki proezd, 4, Moscow, Russian Federation, 125167., Adilgereeva EP; Laboratory of Mutagenesis, Federal State Budgetary Institution, Research Centre for Medical Genetics, Moskvorechie str., 1, Moscow, Russian Federation, 115522., Shukhov OA; Scientific and Advisory Department of Chemotherapy of Myeloproliferative disorders, Federal State-Funded Institution National Research Center for Hematology of the Ministry of Healthcare of the Russian Federation, Novy Zykovki proezd, 4, Moscow, Russian Federation, 125167., Smirnikhina SA; Laboratory of Mutagenesis, Federal State Budgetary Institution, Research Centre for Medical Genetics, Moskvorechie str., 1, Moscow, Russian Federation, 115522., Kochergin-Nikitsky KS; Laboratory of Mutagenesis, Federal State Budgetary Institution, Research Centre for Medical Genetics, Moskvorechie str., 1, Moscow, Russian Federation, 115522., Yakushina VD; Laboratory of Mutagenesis, Federal State Budgetary Institution, Research Centre for Medical Genetics, Moskvorechie str., 1, Moscow, Russian Federation, 115522., Tsaur GA; Regional Children Hospital 1, S. Deryabinoy str., 32, Ekaterinburg, Russian Federation, 620149.; Research Institute of Medical Cell Technologies, Soboleva str., 25, Ekaterinburg, Russian Federation, 620905.; Federal State Budgetary Educational Institution of Higher Education, Urals State Medical University of the Ministry of Healthcare of the Russian Federation, Repina str., 3, Ekaterinburg, Russian Federation, 620028., Mordanov SV; Laboratory of Medical Genetics, The Rostov State Medical University, Nahichevansky av., 29, Rostov-on-Don, Russian Federation, 344022., Turkina AG; Scientific and Advisory Department of Chemotherapy of Myeloproliferative disorders, Federal State-Funded Institution National Research Center for Hematology of the Ministry of Healthcare of the Russian Federation, Novy Zykovki proezd, 4, Moscow, Russian Federation, 125167., Kutsev SI; Laboratory of Mutagenesis, Federal State Budgetary Institution, Research Centre for Medical Genetics, Moskvorechie str., 1, Moscow, Russian Federation, 115522.; Department of Molecular and Cellular Genetics, State Budgetary Educational Institution of Higher Professional Education 'Russian National Research Medical University named after N.I. Pirogov' of Ministry of Health of the Russian Federation, Ostrovityanova str., 1, Moscow, Russian Federation, 117997.

المصدر: BMC medical genomics [BMC Med Genomics] 2019 Mar 13; Vol. 12 (Suppl 2), pp. 37. Date of Electronic Publication: 2019 Mar 13.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101319628 Publication Model: Electronic Cited Medium: Internet ISSN: 1755-8794 (Electronic) Linking ISSN: 17558794 NLM ISO Abbreviation: BMC Med Genomics Subsets: MEDLINE

Find this article in full text from Springer Verlag.

Find this article in full text from ProQuest

Full Text Finder

9

دورية أكاديمية

Prospective investigation of applicability and the prognostic significance of bone marrow involvement in patients with neuroblastoma detected by quantitative reverse transcription PCR.

المؤلفون: Druy AE; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation.; Research Institute of Medical Cell Technologies, Yekaterinburg, Russian Federation., Shorikov EV; PET-Technology Center of Nuclear Medicine, Yekaterinburg, Russian Federation., Tsaur GA; Research Institute of Medical Cell Technologies, Yekaterinburg, Russian Federation.; Regional Children's Hospital N1, Yekaterinburg, Russian Federation.; Department of Immunochemistry, Ural Federal University named after the First President of Russia B.N. Yeltsin, Yekaterinburg, Russian Federation., Popov AM; Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russian Federation., Zaychikov AN; Regional Children's Hospital N1, Yekaterinburg, Russian Federation., Tuponogov SN; Regional Children's Hospital N1, Yekaterinburg, Russian Federation., Saveliev LI; Research Institute of Medical Cell Technologies, Yekaterinburg, Russian Federation.; Regional Children's Hospital N1, Yekaterinburg, Russian Federation., Tytgat GAM; Department of Pediatric Oncology, Emma Children's Hospital (EKZ/AMC), Amsterdam, The Netherlands.; Princess Máxima Centre for Pediatric Oncology (PMC), Utrecht, The Netherlands., Fechina LG; Regional Children's Hospital N1, Yekaterinburg, Russian Federation.

المصدر: Pediatric blood & cancer [Pediatr Blood Cancer] 2018 Nov; Vol. 65 (11), pp. e27354. Date of Electronic Publication: 2018 Jul 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE

View record at Wiley

Full Text Finder

10

دورية أكاديمية

[Biological microchip for establishing the structure of fusion transcripts involving MLL in children with acute leukemia].

المؤلفون: Nasedkina TV; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991 Russia.; Rogachev Federal Clinical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, 119117 Russia.; nased@eimb.ru., Ikonnikova AY; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991 Russia., Tsaur GA; Regional Children's Clinical Hospital no. 1, Yekaterinburg, 620149 Russia.; Institute of Medical Cell Technologies, Yekaterinburg, 620026 Russia.; Yeltsin Ural Federal University, Yekaterinburg, 620002 Russia., Karateeva AV; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991 Russia., Ammour YI; Rogachev Federal Clinical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, 119117 Russia., Avdonina MA; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991 Russia., Karachunskii AI; Rogachev Federal Clinical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, 119117 Russia., Zasedatelev AS; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, 119991 Russia.

المصدر: Molekuliarnaia biologiia [Mol Biol (Mosk)] 2016 Nov-Dec; Vol. 50 (6), pp. 968-977.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Izdatelstvo Nauka Country of Publication: Russia (Federation) NLM ID: 0105454 Publication Model: Print Cited Medium: Print ISSN: 0026-8984 (Print) Linking ISSN: 00268984 NLM ISO Abbreviation: Mol Biol (Mosk) Subsets: MEDLINE

مواضيع طبية MeSH: Gene Expression Regulation, Leukemic* , Transcription, Genetic*, Gene Expression Profiling/*instrumentation , Histone-Lysine N-Methyltransferase/*biosynthesis , Leukemia, Myeloid, Acute/*metabolism , Myeloid-Lymphoid Leukemia Protein/*biosynthesis , Oligonucleotide Array Sequence Analysis/*instrumentation , Oncogene Proteins, Fusion/*biosynthesis , Precursor Cell Lymphoblastic Leukemia-Lymphoma/*metabolism, Child ; Child, Preschool ; Female ; Gene Expression Profiling/methods ; Histone-Lysine N-Methyltransferase/genetics ; Humans ; Infant ; Infant, Newborn ; Leukemia, Myeloid, Acute/genetics ; Male ; Myeloid-Lymphoid Leukemia Protein/genetics ; Oligonucleotide Array Sequence Analysis/methods ; Oncogene Proteins, Fusion/genetics ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics

تنقيح النتائج